risks associated with semaglutide Wegovy may raise risk of ischemic optic neuropathy 👁️ The obesity drug semaglutide, marketed as Wegovy, was a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic risks of taking semaglutide What
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6























